Kater, A. P., Jiang, Y., Chyla, B. and Seymour, J. F. (2020) “Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab”, Haematologica. Pavia, Italy, 105(7), pp. e382-e383. doi: 10.3324/haematol.2020.253849.